Product Test Results

Plant Health Care PLC
06 December 2004


For immediate release: 6 December 2004


  PLANT HEALTH CARE ANNOUNCES SPECTACULAR RESULTS OF INDEPENDENT FORMONONETIN
                                      TESTS

                 Results show crop yield increases of up to 42%


Plant Health Care plc ('PHC' or the 'Company'), a leading provider of natural
products for plants and soil, is pleased to announce very encouraging results
following independent trials of its newly acquired Formononetin product.

The tests were carried out in the United States on soybean and corn seeds by two
independent professional research groups, Beck Hybrid and AgriBusiness Group,
and took place in six locations with differing soil and climatic
characteristics. Yield increases of corn and soybean crops from seed treated
with Formononetin were substantial. In the case of corn, yields improved by up
to 25% and soybean yields improved by up to 42%. The benefits were most apparent
in those areas where soil quality was low and the weather was poor.

In the UK and Europe where GM farming is currently restricted, the directors
believe that the use of Formononetin will allow farmers to produce yields
equivalent to or exceeding those of GM crops. Similarly if Formononetin was used
in areas of the world where soil quality is particularly poor and rainfall is
unpredictable the directors believe the potential for improved growth and
increased yields is tremendous. There is scope for broad agricultural
application of Formononetin and the positive results shown will help facilitate
uptake of the product, as part of Plant Health Care's full product range.

Background: PHC synthesizes Formononetin, a compound originally identified from
plant roots that stimulates the growth of mycorrhizal fungi already existing in
soil. In natural soil, mycorrhizal fungi are readily available to plants;
however, in urban landscapes, degraded lands and most agricultural lands,
mycorrhizal fungi are often not present in adequate quantities. Stimulating
plant roots with mycorrhizal fungi products can increase the surface area of the
root system and improve the health and survivability of plants. The addition of
Formononetin to soil or seed has been demonstrated in numerous field trials to
increase the yields of row crops such as corn, soybeans and cotton, even when
used in very small quantities. PHC acquired the Formononetin synthesis
technology through its acquisition of VAMTech LLC last October.

John Brady, Plant Health Care's CEO, said: 'We strongly believe that
Formononetin can revolutionise the treatment of row crops. We have successfully
been using Formononentin in our products for over three years. These new,
independent test results further demonstrate that natural biological-based
products can produce results that are equivalent to, or exceed, conventional
plant care products. Our test marketing has shown there is huge demand for
effective, natural products for row crops. Mass production of Formononetin is
already underway and we have initiated field-testing in the US, Australia,
Africa and Europe. This product has significant revenue potential and we expect
to start generating revenue in 2005, with considerable market penetration in
2006. We are confident that our Formononetin product will make a major impact in
the production of commodity row crops in the future.'

For further information please contact:

Plant Health Care plc              Tavistock Communications
John Brady, CEO                    Jeremy Carey/Katy Pratt
Tel: [phone]              Tel: [phone]
                                   Email: [e-mail]





                      This information is provided by RNS
            The company news service from the London Stock Exchange